IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q1 2019 Holdings

Filed 2019-05-15 | 11 holdings | $124.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$124.0M524,65899.5%
Allergan PLCSHSG0177J108$127.1K868,0000.1%
Ironwood Pharmaceuticals Inc.(IRWD)COM CLA46333X108$102.0K7,542,2000.1%
Medicines CoCOM584688105$101.6K3,636,0000.1%
Innoviva Inc(INVA)COM45781M101$84.5K6,026,1000.1%
Abbvie Inc(ABBV)COM00287Y109$80.0K1,0000.1%
Puma Biotechnology Inc(PBYI)COM74587V107$55.0K1,417,0000.0%
Intercept Pharmaceuticals Inc(ICPTUSD)COM45845P108$35.8K320,0000.0%
Mersana Therapeutics IncCOM59045L106$19.7K3,750,0000.0%
Jazz Pharmaceuticals Inc(JAZZ)COMG50871105$14.3K100,0000.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$731,0000.0%